🔗 Share this article

The Nobel Prize in Physiology or Medicine was awarded for transformative findings that illuminate how the body's defense network attacks harmful pathogens while protecting the body's own cells.

A trio of renowned researchers—from Japan Prof. Sakaguchi and American scientists Dr. Brunkow and Dr. Ramsdell—received this accolade.

Their research identified unique "sentinels" within the immune system that remove rogue defense cells that could harming the organism.

These findings are now paving the way for innovative therapies for autoimmune diseases and cancer.

These laureates will share a monetary award valued at 11m SEK.

Crucial Findings

"The research has been essential for understanding how the body's defenses functions and the reason we don't all develop serious self-attack conditions," commented the chair of the Nobel Committee.

This team's research explain a fundamental question: How does the immune system defend us from numerous infections while leaving our healthy cells unharmed?

The body's protection system uses immune cells that search for signs of disease, even pathogens and germs it has never encountered.

These defenders utilize detectors—known as receptors—that are generated randomly in a vast number of variations.

That gives the defense network the capacity to combat a broad range of threats, but the randomness of the process unavoidably produces immune cells that can attack the host.

Protectors of the Immune System

Scientists previously knew that some of these harmful white blood cells were destroyed in the immune organ—where immune cells develop.

The latest award honors the identification of regulatory T-cells—known as the body's "peacekeepers"—which patrol the body to disarm any defenders that assault the healthy cells.

We know that this mechanism fails in self-attack conditions such as juvenile diabetes, MS, and RA.

The prize committee added, "The discoveries have established a novel area of research and spurred the creation of innovative treatments, for example for tumors and autoimmune diseases."

In cancer, T-regs block the body from fighting the growth, so studies are focused on lowering their quantity.

For autoimmune diseases, trials are exploring boosting T-reg cells so the body is not being harmed. A comparable method could also be effective in minimizing the risks of organ transplant failure.

Pioneering Experiments

Professor Shimon Sakaguchi, of Osaka University, performed tests on mice that had their thymus removed, leading to self-attack conditions.

The researcher showed that injecting defense cells from healthy mice could prevent the illness—implying there was a system for preventing immune cells from harming the body.

Dr. Brunkow, affiliated with the a research center in Seattle, and Dr. Ramsdell, currently at Sonoma Biotherapeutics in San Francisco, were studying an genetic immune disorder in rodents and humans that led to the identification of a gene vital for the way regulatory T-cells operate.

"Their groundbreaking work has uncovered how the immune system is kept in check by T-reg cells, preventing it from accidentally targeting the healthy cells," said a prominent physiology expert.

"The research is a remarkable illustration of how fundamental biological study can have far-reaching consequences for public health."